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Summary We report an extraordinary case of collision tumor consisting of a lung adenocarci-
noma and a metastatic adenoid cystic carcinoma in a 56 year-old man. He was diagnosed with a
pulmonary nodule 11 years after treatment of an adenoid cystic carcinoma of the right maxillary
sinus. A non-small cell carcinoma was observed when a transbronchial biopsy was performed.
The other component of the nodule was only diagnosed with pathological examination of the
resection specimen.
© 2010 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L. All rights
reserved.
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Tumor pulmonar de colisão: metástase de carcinoma adenóide cístico e
adenocarcinoma pulmonar
Resumo Descrevemos um caso único de tumor de colisão constituído por um adenocarcinoma
de pulmão e uma metástase dum carcinoma adenóide cístico em um homem de 56 anos de idade.
Ao doente foi diagnosticado um nódulo pulmonar 11 anos após o tratamento de um carcinomacístico
adenóide cístico do seio maxilar direito. O carcinoma de pulmão de não pequenas células foi
observado no momento da realizac¸ão de uma biópsia transbrônquica. O outro componente do
nódulo foi diagnosticado depois do exame histológico do material ressecado.
© 2010 Sociedade Portuguesa de Pneumologia. Publicado por Elsevier España, S.L. Todos os
direitos reservados.∗ Corresponding author.
E-mail address: montseblancoramos@hotmail.com (M. Blanco).
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Metastatic adenoid cystic carcinoma and lung adenocarcinoma
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tFigure 1 CT image showing the nodule in the middle lobe.
The two malignancies may originate from the same organ
or occur as metastases from other sites. There is no histo-
logical admixture or intermediate-transition cell population
zone. These tumors are difﬁcult to diagnose preoperatively
and pathological identiﬁcation of the dual components is
often the only way to make a correct diagnosis.1
Adenoid cystic carcinoma (ACC) is a malignant tumor
that is commonly classiﬁed with the salivary gland tumors,
although it may arise at any site where mucous glands exist.
This tumor exhibits a unique malignant proﬁle, which is
characterized by slow growth and high propensity to sys-
temic metastases. The lung is the most common site of
metastasis, as pulmonary metastases have been reported
in more than 38% of patients with ACC of the head and
neck. Most patients with metastatic disease are relatively
asymptomatic and may remain so for long periods.2,3
Several case reports have been published in the litera-
ture, which describe a primary pulmonary collision tumor
consisting of large-cell carcinoma and adenocarcinoma4 or
squamous cell carcinoma and T-cell lymphoma.5 To our
knowledge, this is the ﬁrst report that describes a case
of collision cancer in the lung consisting of a lung ade-
nocarcinoma and a metastasis of an ACC diagnosed with
immunohistochemical techniques performed after surgery.
Case report
A 56-year-old man with a previous history of adenoid
cystic carcinoma of the right maxillary sinus (pT4N0Mx)
that had been treated by right radical hemimaxillectomy
and radiotherapy 11 years earlier was admitted to our
institution after referral from his oncologist. During the reg-
ular follow-up, a computed tomography (CT) scan showed
a 2.5 cm diameter nodule, with irregular morphology in
the middle lobe, which was in contact with the middle
lobe brochus and right inferior lobar artery (Fig. 1). A
transbronchial biopsy with bronchoscopy was performed
showing an epithelial neoplastic cell proliferation with large
cytoplasms and hyperchromatic nuclei. Neoplastic cells
expressed Cytokeratin AE1/AE3, Cytokeratin 7 and TTF-1.
With these features, non-small cell carcinoma with immuno-
histochemical stigmas of adenocarcinoma was diagnosed. A
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ositron emission tomography (PET) demonstrated a focus
f increased FDG uptake in the right hilum contacting with
he middle lobe.
It was necessary to perform a middle-lower bilobectomy
s the nodule was located in the hilum of the middle lobe and
ffected the major ﬁssure. Mediastinal lymph node dissec-
ion was performed including stations 7, 8, 9 and 4R. The
ostoperative course was uneventful, and the patient was
ischarged on day 9 after the operation.
Histologically, the nodule located in the middle lobe
as a collision tumor of 2.5 cm diameter formed by a
ung adenocarcinoma with a poorly differentiated grade
1.1 cm× 1 cm) and a metastatic ACC (1.5 cm× 1 cm) 0.2 cm
way from the primary tumor. We did not observe histo-
ogical admixture or an intermediate cell population zone
Fig. 2a). A subpleural nodule of ACC was also observed
n the right lower lobe (0.5 cm). There was no evidence
f vascular invasive tumor, the resection bronchial margin
as negative and all the lymph nodes were free (Fig. 2).
n the immunohistochemical work-up, one area consisted
f glandular neoplasic proliferation with poorly differenti-
ted areas and large cells with severe cytologic atypia TTF-1
ositive (Fig. 2b) and C-kit (CD117) negative (Fig. 2d). The
ther area was formed by basophil epithelial nests with the
resence of mucoid material inside. These cells showed a
oderate grade of cytologic atypia and were positive for
-kit (Fig. 2e) and negative for TTF-1 (Fig. 2c).
The patient is alive and disease-free without any further
reatment 17 months following surgery.
iscussion
he occurrence of multiple malignancies in the same
natomical site in organs such as the thyroid, breast and
ymph nodes has been previously described.6 In the lung,
ingle cases of bronchogenic carcinoma have been unex-
ectedly found when pulmonary resection was performed
or metastatic lung cancer.7 Nevertheless, the occurrence of
ynchronous colliding tumors remains an extremely uncom-
on condition with a very limited number of cases having
een published in the literature.
ACC is a rare form of malignant neoplasm that usually
riginates within the major and minor salivary glands of
he head and neck. Clinically, this tumor presents insidi-
usly and is generally advanced when diagnosed. ACC seldom
etastasizes to regional lymph nodes. Nevertheless, a dis-
ant spread to the lungs and bones occurs frequently. The
istant metastasis can cause death as long as 10--20 years
fter initial treatment.8 In our case, as described in the
iterature, metastasis appeared in the lung 11 years after
reatment. Nevertheless we did not suspect the existence of
n ACC metastasis inside the nodule because there were no
ocal recurrences during the follow-up period and we found a
ositive transbronchial biopsy for non-small cell carcinoma.
Immunohistochemical study was important for the ﬁnal
iagnosis; part of the nodule was negative for TTF-1 and
ositive for C-kit, which is a transmembrane type III recep-
or tyrosine kinase that has recently been reported to be
xpressed in ACC.9 C-kit is activated by binding of its lig-
nd, stem cell factor. Binding of stem cell factor initiates
phosphorylation cascade that ultimately leads to activa-
ion of various transcription factors that regulate apoptosis,
44 M. Blanco et al.
Figure 2 (a) Section of the collision tumor stained with hematoxilyn and eosin. We can observe the lung adenocarcinoma on the left
side of the bronchial lumen and the adenoid cystic carcinoma on the right; objective magniﬁcation 20×. (b) Immunohistochemical
detection of TTF-1 was positive in the lung adenocarcinoma; objective magniﬁcation 400×. (c) Immunostaining with TTF-1 in the
adenoid cystic carcinoma was negative; objective magniﬁcation 400×. (d) Immunohistochemical detection of C-kit was negative
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ell differentiation and proliferation. Kit protein expression
s important in the development of normal human tissues
nd in many human neoplasms including mastocytosis, gas-
rointestinal stromal cell tumors, melanoma, breast cancer,
ynecologic cancers, thyroid neoplasms, etc.10,11 Recently,
it expression has been identiﬁed in several types of salivary
m
i-kit expression in the adenoid cystic carcinoma with a basal
land tumors. In these tumors, kit expression has been most
xtensively documented in adenoid cystic carcinomas with
n expression frequency ranging from 67 to 100.12If we consider the origin of ACC, we must distinguish
etastatic ACC from primary ACC of the lung. Pulmonar ACC
s a malignant tumor arising in the tracheobronchial glands
aMetastatic adenoid cystic carcinoma and lung adenocarcinom
distributed in the airway submucosa, with a similar mor-
phology to ACC arising in the salivary glands. Because of the
site of origin, pulmonary ACC is more common in the cen-
tral bronchi than in the segmental bronchi. Reports of ACC
originating in the peripheral lung are rare. In addition, in
cases of occurrence in the periphery, lung metastases from
a salivary gland tumor must be ruled out.13 In our case,
the characteristics we observed gave us the ﬁnal diagno-
sis of a metastatic ACC. These characteristics were: (1) The
obvious difference in the histological pattern between the
two tumors. Moreover, we did observe no histological admix-
ture or an intermediate cell population zone between both
tumors. (2) The different immunohistochemical expression
of both tumors for C-kit and TTF-1. (3) The existence of
another subpleural nodule in the right lower lobe. (4) The
oncology history of the patient.
In conclusion metastasis in ACC can manifest itself very
late, and thus, long-term follow-up and a high index of suspi-
cion is necessary to diagnose them early. This was observed
in the present case. We would like to emphasize the role of
detailed histopathologic analysis and the use of immunohis-
tochemistry in better identifying lung neoplasms.
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